Simplex Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,900
Closed -$1K 10281
2023
Q3
$1K Buy
4,900
+300
+7% +$659 ﹤0.01% 8496
2023
Q2
$10K Buy
4,600
+3,600
+360% +$7.47K ﹤0.01% 7460
2023
Q1
$2K Sell
1,000
-1,100
-52% -$2.17K ﹤0.01% 8597
2022
Q4
$3K Sell
2,100
-9,700
-82% -$24.2K ﹤0.01% 8480
2022
Q3
$30K Buy
11,800
+10,300
+687% +$25.6K ﹤0.01% 7092
2022
Q2
$2K Buy
+1,500
New +$3.27K ﹤0.01% 9475
2021
Q4
Sell
-36,800
Closed -$266K 11739
2021
Q3
$266K Hold
36,800
﹤0.01% 5102
2021
Q2
$250K Buy
36,800
+36,607
+18,967% +$296K ﹤0.01% 5310
2021
Q1
$136K Buy
193
+92
+91% +$662 ﹤0.01% 5322
2020
Q4
$63K Buy
101
+47
+87% +$277 ﹤0.01% 5940
2020
Q3
$29K Buy
54
+21
+64% +$104 ﹤0.01% 6116
2020
Q2
$17K Sell
33
-16
-33% -$71 ﹤0.01% 6346
2020
Q1
$15K Sell
49
-166
-77% -$612 ﹤0.01% 6200
2019
Q4
$86K Buy
215
+57
+36% +$198 ﹤0.01% 4670
2019
Q3
$68K Buy
+158
New +$632 ﹤0.01% 4723
2019
Q2
Sell
-22
Closed -$11K 8017
2019
Q1
$11K Buy
22
+16
+267% +$103 ﹤0.01% 6126
2018
Q4
$3K Sell
6
-15
-71% -$114 ﹤0.01% 6484
2018
Q3
$20K Sell
21
-6
-22% -$61 ﹤0.01% 5966
2018
Q2
$27K Sell
27
-68
-72% -$769 ﹤0.01% 5634
2018
Q1
$25K Sell
95
-75
-44% -$1.12K ﹤0.01% 3144
2017
Q4
$22K Sell
170
-113
-40% -$2.36K ﹤0.01% 3228
2017
Q3
$135K Buy
283
+98
+53% +$2.28K 0.01% 1482
2017
Q2
$31K Sell
185
-620
-77% -$13.7K ﹤0.01% 2862
2017
Q1
$49K Buy
+805
New +$12.7K ﹤0.01% 2400

Simplex Trading's PRTK Position: Q3 2023 in Review

Simplex Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 22 shares — an estimated $48 sold.

Simplex Trading first reported a position in PRTK in Q4 2014 and held it in 19 quarters. The position peaked at $911K in Q3 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Simplex Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 22 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $48.
  • Simplex Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
  • Simplex Trading's Paratek Pharmaceuticals, Inc. position peaked at $911K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.